Pune, India, March 01, 2023 (GLOBE NEWSWIRE) -- The global softgel capsules market size was valued at USD 6.52 Billion in 2020. The market is projected to grow from USD 6.94 billion in 2021 to USD 9.59 Billion in 2027, exhibiting a CAGR of 5.5% during the forecast period. The rising launch of vegan products by numerous renowned companies across the globe is set to affect growth positively. As these are 100% and do not have any potential health risk, their demand is surging rapidly. For instance, in November 2020, Aenova unveiled its latest vegan soft capsules called VegaGels. They conform to the Chinese, E.U., and U.S. regulatory specifications. Fortune Business Insights™ give this information in a new study, titled, “Softgel Capsules Market, 2021-2027.”
Key Industry Development
July 2021 - The Aenova Group announced the commencement of a new canning and bottling line for soft gelatin capsules at Cornu, Romania. It will expand the capacity of the packaging department with cans and bottles and establish itself as a one-stop shop for the production and packaging of soft capsules in all common variants.
Request a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/softgel-capsules-market-103353
| Report Coverage | Details |
| Forecast Period | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR | 5.5% |
| 2027 Value Projection | USD 9.59 Billion |
| Base Year | 2020 |
| Softgel Capsules Market Size in 2021 | USD 6.94 Billion |
| Historical Data | 2016 to 2019 |
| No. of Pages | 216 |
| Segments Covered | By Type, Application, Manufacturers and Geography |
Drivers & Restraints-
Increasing Prevalence of Cardiovascular Disorders to Augment Growth
The number of clinical trials is rising at a fast pace as more and more companies are coming forward to evaluate the effectiveness of these capsules. Besides, the increasing cases of chronic diseases, such as cardiovascular diseases is another major factor that is set to accelerate the softgel capsules market growth in the upcoming years. As per the Centers for Disease Control and Prevention (CDC), approximately 12.1% of adults in the U.S. were diagnosed with cardiovascular disorders in 2018. However, the need to prevent generic competition and patent expiration is high in the market. It may obstruct growth.
Key Takeaways
- The market is projected to rise at a CAGR of 5.5% during the forecast period (2021-2027).
- The increasing prevalence of chronic ailments such as cardiovascular diseases is the key factor driving the global market.
- Capsugel (Lonza) and Catalent, Inc. are the top players in the global market.
- North America is expected to hold the highest market share.
Segments-
Pharmaceutical Companies Segment to Dominate Stoked by Higher Production of Capsules
Based on the type, the market is divided into gelatin capsules and non-animal softgel capsules. By the application, it is fragmented into prescription medicines and health & dietary supplements. Lastly, based on manufacturers, it is segmented into pharmaceutical companies, nutraceutical companies, and others. Amongst these, the pharmaceutical companies segment is anticipated to remain at the forefront in the near future because of the increasing production of these capsules by these companies. The pharmaceutical companies segment held 56.4% in terms of the softgel capsules market share in 2020.
Report Coverage-
Our in-depth research reports offer comprehensive coverage of the focus industry, ensuring a deep and holistic understanding of the market. It also offers granular and actionable data. We strive to ensure that you receive the best strategies for increasing sales of your products. Our key mission is service orientation. We also conduct primary and secondary research to track the latest innovations, regulatory developments, and competitive landscape occurring in the softgel capsules industry.
To Get This Report Customized, Visit: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/softgel-capsules-market-103353
Regional Insights-
North America to Lead Owing to Rising Launch of Novel Products by Manufacturers
Geographically, North America procured USD 2.29 billion in terms of revenue in 2020. This growth is attributable to the increasing launch of unique products by reputed manufacturers of these capsules in the region. In Europe, the market is anticipated to grow considerably on account of the surging investments by various countries in R&D activities. Asia Pacific is estimated to showcase the highest CAGR throughout the forthcoming years because of the rising incidence of chronic ailments.
Competitive Landscape-
Key Players Focus on Launching Innovative Capsules to Fulfil High Consumer Demand
The market is consolidated with only three companies in the leading position. Most of them are focusing on the launch of state-of-the-art products to keep up with the high consumer demand worldwide. Below are the two latest industry developments:
- October 2020: Catalent introduced its new OptiGel DR technology to manufacture and formulate delayed/enteric release softgels. These would be formed by a blend of gelatin and pectin, thereby eliminating the requirement of another capsule coating step.
- June 2020: Lonza Capsules and Health Ingredients launched new capsules named Capsugel® DBcaps® to tackle the important hurdles amid double-blinded clinical trials.
A list of prominent softgel capsules manufacturers operating in the global market:
- Capsugel (Lonza) (New Jersey, U.S.)
- Sirio Pharma Co., Ltd. (Guangdong, China)
- Catalent, Inc (New Jersey, U.S.)
- Aenova Holding GmbH (Munich, Germany)
- Fuji Capsule Co., Ltd. (Shizuoka, Japan)
- CAPTEK Softgel International Inc. (California, U.S.)
- Curtis Health Caps (Wielkopolskie, Poland)
- EuroCaps Ltd (South Wales, UK)
- Other prominent players
Ask An Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cancer-biomarkers-market-100630
Table Of Content
- Global Softgel Capsules Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Gelatin Capsules
- Non-animal Softgel Capsules
- Starch
- Pullulan
- Others
- Market Analysis, Insights and Forecast – By Application
- Prescription Medicines
- Health & Dietary Supplements
- Market Analysis, Insights and Forecast – By Manufacturers
- Pharmaceutical Companies
- Nutraceutical Companies
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Softgel Capsules Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Gelatin Capsules
- Non-animal Softgel Capsules
- Starch
- Pullulan
- Others
- By Application
- Prescription Medicines
- Health & Dietary Supplements
- By Manufacturers
- Pharmaceutical Companies
- Nutraceutical Companies
- Others
- By Country
- The U.S.
- Canada
TOC Continued…!
Request a Complete TOC: https://www.fortunebusinessinsights.com/toc/softgel-capsules-market-103353
Explore Fortune Business Insight’s Healthcare Market Trending Reports:
Medical Lasers Market Size, Share, Opportunities & Analysis
Urinary Catheter Market Overview, Industry Share and Forecast
Examination Lights Market Size, Growth, Demand and Forecast
Smart Contact Lenses Market Size, Growth Opportunities & Analysis
Immunoglobulins Market Overview, Size, Share, Opportunities
FAQ’s
Who are the key players in the softgel capsules market?
Capsugel (Lonza) and Catalent, Inc. are the top players in the global market.
What is the softgel capsules market growth?
The Softgel Capsules market is projected to grow from USD 6.94 billion in 2021 to USD 9.59 billion in 2027 at a CAGR of 5.5% in the 2021-2027 period.
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
